ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000232453.1	AKT inhibitor VIII	Chronic Lymphocytic Leukemia	0.032128701	Resistant
ENSG00000232453.1	AKT inhibitor VIII	Thyroid carcinoma	0.027193035	Resistant